

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrion distribution (GO:0048311) | 4.86679222 |
| 2 | response to gravity (GO:0009629) | 4.66926408 |
| 3 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.65885096 |
| 4 | cellular response to zinc ion (GO:0071294) | 4.46109717 |
| 5 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.34268743 |
| 6 | cellular response to vitamin D (GO:0071305) | 4.27858895 |
| 7 | NIK/NF-kappaB signaling (GO:0038061) | 4.18824265 |
| 8 | T cell lineage commitment (GO:0002360) | 4.10214460 |
| 9 | short-term memory (GO:0007614) | 4.02291909 |
| 10 | regulation of protein heterodimerization activity (GO:0043497) | 3.98599971 |
| 11 | cellular response to arsenic-containing substance (GO:0071243) | 3.97980449 |
| 12 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.88714512 |
| 13 | chemosensory behavior (GO:0007635) | 3.80878797 |
| 14 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.68769182 |
| 15 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.63560733 |
| 16 | mitotic G1/S transition checkpoint (GO:0044819) | 3.60648085 |
| 17 | nucleoside diphosphate catabolic process (GO:0009134) | 3.59102312 |
| 18 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.57570376 |
| 19 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.57570376 |
| 20 | activation of MAPKKK activity (GO:0000185) | 3.56370694 |
| 21 | cellular response to interferon-beta (GO:0035458) | 3.55432227 |
| 22 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.54145705 |
| 23 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.50987005 |
| 24 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.50987005 |
| 25 | negative regulation of mast cell activation (GO:0033004) | 3.48650119 |
| 26 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.46798468 |
| 27 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.46000780 |
| 28 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042) | 3.41940664 |
| 29 | DNA deamination (GO:0045006) | 3.41087483 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38574707 |
| 31 | release of cytochrome c from mitochondria (GO:0001836) | 3.28973086 |
| 32 | regulation of penile erection (GO:0060405) | 3.25278896 |
| 33 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.22060090 |
| 34 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.21252148 |
| 35 | G1 DNA damage checkpoint (GO:0044783) | 3.20235416 |
| 36 | regulation of autophagic vacuole assembly (GO:2000785) | 3.19965225 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.17411205 |
| 38 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.16982095 |
| 39 | protein targeting to ER (GO:0045047) | 3.15632547 |
| 40 | kynurenine metabolic process (GO:0070189) | 3.14941042 |
| 41 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.14123243 |
| 42 | adaptation of signaling pathway (GO:0023058) | 3.12974827 |
| 43 | cytidine metabolic process (GO:0046087) | 3.10571115 |
| 44 | cytidine catabolic process (GO:0006216) | 3.10571115 |
| 45 | cytidine deamination (GO:0009972) | 3.10571115 |
| 46 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.08637880 |
| 47 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.07442665 |
| 48 | cotranslational protein targeting to membrane (GO:0006613) | 3.05332135 |
| 49 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.04350531 |
| 50 | positive regulation of T cell apoptotic process (GO:0070234) | 3.04339142 |
| 51 | T cell apoptotic process (GO:0070231) | 3.01858762 |
| 52 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.01626485 |
| 53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99553776 |
| 54 | viral transcription (GO:0019083) | 2.99381736 |
| 55 | positive regulation of muscle cell apoptotic process (GO:0010661) | 2.98646117 |
| 56 | endoderm formation (GO:0001706) | 2.98377049 |
| 57 | tryptophan catabolic process (GO:0006569) | 2.98113618 |
| 58 | indole-containing compound catabolic process (GO:0042436) | 2.98113618 |
| 59 | indolalkylamine catabolic process (GO:0046218) | 2.98113618 |
| 60 | protein localization to endoplasmic reticulum (GO:0070972) | 2.96355999 |
| 61 | negative regulation of JUN kinase activity (GO:0043508) | 2.96314647 |
| 62 | specification of organ identity (GO:0010092) | 2.95300764 |
| 63 | positive regulation of protein deacetylation (GO:0090312) | 2.94743735 |
| 64 | response to type I interferon (GO:0034340) | 2.93313821 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92756200 |
| 66 | type I interferon signaling pathway (GO:0060337) | 2.92312951 |
| 67 | cellular response to type I interferon (GO:0071357) | 2.92312951 |
| 68 | translational termination (GO:0006415) | 2.92144634 |
| 69 | tachykinin receptor signaling pathway (GO:0007217) | 2.91860423 |
| 70 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90617306 |
| 71 | ribosomal small subunit assembly (GO:0000028) | 2.84101311 |
| 72 | regulation of protein homodimerization activity (GO:0043496) | 2.83872147 |
| 73 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.83833913 |
| 74 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.82156815 |
| 75 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.80631290 |
| 76 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.79661650 |
| 77 | T cell migration (GO:0072678) | 2.79215523 |
| 78 | positive regulation of protein oligomerization (GO:0032461) | 2.79135335 |
| 79 | negative regulation of viral genome replication (GO:0045071) | 2.78277243 |
| 80 | ribonucleoside diphosphate metabolic process (GO:0009185) | 2.77872016 |
| 81 | cellular response to vitamin (GO:0071295) | 2.75480072 |
| 82 | response to histamine (GO:0034776) | 2.70148327 |
| 83 | myeloid dendritic cell differentiation (GO:0043011) | 2.69724400 |
| 84 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.69022452 |
| 85 | isotype switching (GO:0045190) | 2.69022452 |
| 86 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.69022452 |
| 87 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.68074929 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.67053339 |
| 89 | regulation of vacuole organization (GO:0044088) | 2.66377851 |
| 90 | tryptophan metabolic process (GO:0006568) | 2.65586753 |
| 91 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.64756312 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.63844824 |
| 93 | pyrimidine-containing compound salvage (GO:0008655) | 2.62318150 |
| 94 | pyrimidine nucleoside salvage (GO:0043097) | 2.62318150 |
| 95 | T-helper 1 type immune response (GO:0042088) | 2.61127708 |
| 96 | positive regulation of interleukin-2 production (GO:0032743) | 2.61092034 |
| 97 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.60096399 |
| 98 | positive regulation of DNA biosynthetic process (GO:2000573) | 2.59693733 |
| 99 | programmed necrotic cell death (GO:0097300) | 2.57792200 |
| 100 | lymphocyte apoptotic process (GO:0070227) | 2.57597063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.33181940 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.16143511 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.97479386 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.85314711 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.77418659 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.68301889 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.54436976 |
| 8 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.29750844 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.21975387 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20937277 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14012616 |
| 12 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.07562567 |
| 13 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.06185474 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05272711 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98535434 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.98251642 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91431437 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81455564 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.81444601 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80006148 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79201444 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.78918499 |
| 23 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75957005 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72510682 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.70189290 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67808828 |
| 27 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.66923498 |
| 28 | P68_20966046_ChIP-Seq_HELA_Human | 1.65506528 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65234896 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64601195 |
| 31 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63263134 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60068379 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.59476097 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.59422001 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.58488949 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.54303563 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53914108 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.53598801 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.50960351 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49428255 |
| 41 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.45240958 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44016862 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40858305 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39219664 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.38879470 |
| 46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.37172371 |
| 47 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.34608577 |
| 48 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.34411657 |
| 49 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.34102341 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33314148 |
| 51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.31136937 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.29539985 |
| 53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28056879 |
| 54 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.26889863 |
| 55 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25936008 |
| 56 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25428614 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24738603 |
| 58 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23842780 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16446884 |
| 60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16127152 |
| 61 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15547379 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13939753 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13715373 |
| 64 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.11937546 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.11496718 |
| 66 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10938971 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10904914 |
| 68 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.09905509 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.08782820 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08505447 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08504804 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08222621 |
| 73 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.08097282 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.07719836 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07709878 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07498728 |
| 77 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07061158 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07027412 |
| 79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.06333180 |
| 80 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04945881 |
| 81 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04828024 |
| 82 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04043894 |
| 83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03508914 |
| 84 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02968672 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99964436 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99454709 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98946377 |
| 88 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98621906 |
| 89 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.98112441 |
| 90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97636147 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96314700 |
| 92 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.96072249 |
| 93 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94336232 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93630270 |
| 95 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93398432 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92705590 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92366655 |
| 98 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91884742 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91759376 |
| 100 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91552310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002163_abnormal_gland_morphology | 5.34888147 |
| 2 | MP0005623_abnormal_meninges_morphology | 4.16067347 |
| 3 | MP0005379_endocrine/exocrine_gland_phen | 3.60410728 |
| 4 | MP0001348_abnormal_lacrimal_gland | 3.59085912 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.55268837 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 3.31500103 |
| 7 | MP0000685_abnormal_immune_system | 3.28841031 |
| 8 | MP0010368_abnormal_lymphatic_system | 3.10152148 |
| 9 | MP0002166_altered_tumor_susceptibility | 3.03057437 |
| 10 | MP0004885_abnormal_endolymph | 2.80576732 |
| 11 | MP0005671_abnormal_response_to | 2.74571468 |
| 12 | MP0005084_abnormal_gallbladder_morpholo | 2.45093829 |
| 13 | MP0002006_tumorigenesis | 2.43043860 |
| 14 | MP0001790_abnormal_immune_system | 2.27363834 |
| 15 | MP0005387_immune_system_phenotype | 2.27363834 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.22645877 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.21451915 |
| 18 | MP0005451_abnormal_body_composition | 2.18800029 |
| 19 | MP0009053_abnormal_anal_canal | 2.06065844 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.02938484 |
| 21 | MP0001800_abnormal_humoral_immune | 1.94117373 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.79226817 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.74242774 |
| 24 | MP0002928_abnormal_bile_duct | 1.70644357 |
| 25 | MP0005220_abnormal_exocrine_pancreas | 1.68462147 |
| 26 | MP0002723_abnormal_immune_serum | 1.65429604 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.62869538 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.52844623 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.50880265 |
| 30 | MP0001944_abnormal_pancreas_morphology | 1.46985760 |
| 31 | MP0001542_abnormal_bone_strength | 1.45173938 |
| 32 | MP0002693_abnormal_pancreas_physiology | 1.44330216 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.36990276 |
| 34 | MP0001819_abnormal_immune_cell | 1.35609769 |
| 35 | MP0003186_abnormal_redox_activity | 1.33679448 |
| 36 | MP0003787_abnormal_imprinting | 1.31248225 |
| 37 | MP0002398_abnormal_bone_marrow | 1.30778541 |
| 38 | MP0001905_abnormal_dopamine_level | 1.30453004 |
| 39 | MP0001853_heart_inflammation | 1.29099413 |
| 40 | MP0000613_abnormal_salivary_gland | 1.26953125 |
| 41 | MP0000716_abnormal_immune_system | 1.24516022 |
| 42 | MP0000358_abnormal_cell_content/ | 1.21835383 |
| 43 | MP0009785_altered_susceptibility_to | 1.21579198 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.20988412 |
| 45 | MP0002429_abnormal_blood_cell | 1.19950291 |
| 46 | MP0000858_altered_metastatic_potential | 1.14478152 |
| 47 | MP0003950_abnormal_plasma_membrane | 1.13293812 |
| 48 | MP0005025_abnormal_response_to | 1.11240994 |
| 49 | MP0003786_premature_aging | 1.09071853 |
| 50 | MP0002405_respiratory_system_inflammati | 1.07372256 |
| 51 | MP0003868_abnormal_feces_composition | 1.07337442 |
| 52 | MP0003045_fibrosis | 1.03253189 |
| 53 | MP0005193_abnormal_anterior_eye | 1.01054905 |
| 54 | MP0006035_abnormal_mitochondrial_morpho | 1.00547609 |
| 55 | MP0001845_abnormal_inflammatory_respons | 0.99095818 |
| 56 | MP0010094_abnormal_chromosome_stability | 0.98768752 |
| 57 | MP0003693_abnormal_embryo_hatching | 0.97863894 |
| 58 | MP0003303_peritoneal_inflammation | 0.97260887 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.94554549 |
| 60 | MP0003763_abnormal_thymus_physiology | 0.93569165 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 0.92731455 |
| 62 | MP0005310_abnormal_salivary_gland | 0.92653395 |
| 63 | MP0000689_abnormal_spleen_morphology | 0.89522965 |
| 64 | MP0005501_abnormal_skin_physiology | 0.89330926 |
| 65 | MP0001440_abnormal_grooming_behavior | 0.89009743 |
| 66 | MP0003943_abnormal_hepatobiliary_system | 0.87976461 |
| 67 | MP0001879_abnormal_lymphatic_vessel | 0.87530235 |
| 68 | MP0003091_abnormal_cell_migration | 0.85963088 |
| 69 | MP0004947_skin_inflammation | 0.84330541 |
| 70 | MP0005666_abnormal_adipose_tissue | 0.83331866 |
| 71 | MP0002722_abnormal_immune_system | 0.81460049 |
| 72 | MP0003111_abnormal_nucleus_morphology | 0.79124886 |
| 73 | MP0002132_abnormal_respiratory_system | 0.78482577 |
| 74 | MP0001485_abnormal_pinna_reflex | 0.78451260 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.77216621 |
| 76 | MP0008007_abnormal_cellular_replicative | 0.76849143 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.75960245 |
| 78 | MP0003123_paternal_imprinting | 0.74643792 |
| 79 | MP0001661_extended_life_span | 0.73956288 |
| 80 | MP0009764_decreased_sensitivity_to | 0.71999096 |
| 81 | MP0000462_abnormal_digestive_system | 0.70681566 |
| 82 | MP0003436_decreased_susceptibility_to | 0.69844346 |
| 83 | MP0002796_impaired_skin_barrier | 0.68435322 |
| 84 | MP0001216_abnormal_epidermal_layer | 0.66597237 |
| 85 | MP0000343_altered_response_to | 0.66498469 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.66432085 |
| 87 | MP0005381_digestive/alimentary_phenotyp | 0.65470141 |
| 88 | MP0009115_abnormal_fat_cell | 0.61303934 |
| 89 | MP0002653_abnormal_ependyma_morphology | 0.61216173 |
| 90 | MP0010307_abnormal_tumor_latency | 0.60139665 |
| 91 | MP0003011_delayed_dark_adaptation | 0.59926854 |
| 92 | MP0005448_abnormal_energy_balance | 0.59175819 |
| 93 | MP0000703_abnormal_thymus_morphology | 0.57868965 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.56460891 |
| 95 | MP0002060_abnormal_skin_morphology | 0.54988556 |
| 96 | MP0004957_abnormal_blastocyst_morpholog | 0.54155268 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.54037687 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.53970273 |
| 99 | MP0003879_abnormal_hair_cell | 0.53596200 |
| 100 | MP0002419_abnormal_innate_immunity | 0.53004436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papilledema (HP:0001085) | 4.89245759 |
| 2 | Abnormal pancreas size (HP:0012094) | 4.52809680 |
| 3 | Neoplasm of the adrenal cortex (HP:0100641) | 4.03745626 |
| 4 | Abnormality of cochlea (HP:0000375) | 3.96336958 |
| 5 | Poikiloderma (HP:0001029) | 3.66869930 |
| 6 | Agammaglobulinemia (HP:0004432) | 3.45260919 |
| 7 | IgA deficiency (HP:0002720) | 3.38215632 |
| 8 | Exertional dyspnea (HP:0002875) | 3.31282961 |
| 9 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.30613164 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 3.16244624 |
| 11 | Diastasis recti (HP:0001540) | 3.14359382 |
| 12 | Renal Fanconi syndrome (HP:0001994) | 3.13933682 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.10788123 |
| 14 | Squamous cell carcinoma (HP:0002860) | 3.09687751 |
| 15 | Onycholysis (HP:0001806) | 3.06931115 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.06706270 |
| 17 | Pustule (HP:0200039) | 2.98578067 |
| 18 | Lymphopenia (HP:0001888) | 2.95181000 |
| 19 | Premature loss of primary teeth (HP:0006323) | 2.91227583 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 2.90646611 |
| 21 | Hypertensive crisis (HP:0100735) | 2.86360562 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 2.81853020 |
| 23 | Increased density of long bones (HP:0006392) | 2.75331055 |
| 24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.74974787 |
| 25 | Recurrent viral infections (HP:0004429) | 2.73145508 |
| 26 | Persistence of primary teeth (HP:0006335) | 2.71488070 |
| 27 | Morphological abnormality of the inner ear (HP:0011390) | 2.69208519 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.67147859 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.66261686 |
| 30 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.58537843 |
| 31 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.58417557 |
| 32 | Neonatal hypoglycemia (HP:0001998) | 2.57053226 |
| 33 | Shawl scrotum (HP:0000049) | 2.55029395 |
| 34 | Fetal akinesia sequence (HP:0001989) | 2.54029142 |
| 35 | Abnormality of placental membranes (HP:0011409) | 2.52009503 |
| 36 | Amniotic constriction ring (HP:0009775) | 2.52009503 |
| 37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.46479083 |
| 38 | Metaphyseal dysplasia (HP:0100255) | 2.45784046 |
| 39 | Porencephaly (HP:0002132) | 2.39236853 |
| 40 | Ridged nail (HP:0001807) | 2.38036746 |
| 41 | Turricephaly (HP:0000262) | 2.33287010 |
| 42 | Fragile nails (HP:0001808) | 2.32523781 |
| 43 | Adrenal hypoplasia (HP:0000835) | 2.30428573 |
| 44 | Hyperparathyroidism (HP:0000843) | 2.30111078 |
| 45 | Parakeratosis (HP:0001036) | 2.22917363 |
| 46 | Increased intramyocellular lipid droplets (HP:0012240) | 2.22044345 |
| 47 | Amaurosis fugax (HP:0100576) | 2.19944502 |
| 48 | Increased muscle lipid content (HP:0009058) | 2.18682281 |
| 49 | Horseshoe kidney (HP:0000085) | 2.18012252 |
| 50 | Tongue fasciculations (HP:0001308) | 2.17998958 |
| 51 | Chronic hepatic failure (HP:0100626) | 2.17285301 |
| 52 | Abnormality of T cell physiology (HP:0011840) | 2.15280088 |
| 53 | Prolonged neonatal jaundice (HP:0006579) | 2.15173744 |
| 54 | Reticulocytopenia (HP:0001896) | 2.12285136 |
| 55 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.11462959 |
| 56 | Viral hepatitis (HP:0006562) | 2.11192332 |
| 57 | Acrocyanosis (HP:0001063) | 2.11034473 |
| 58 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.08361257 |
| 59 | Asplenia (HP:0001746) | 2.06467116 |
| 60 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.05871034 |
| 61 | Recurrent bronchitis (HP:0002837) | 2.05106050 |
| 62 | Prominent metopic ridge (HP:0005487) | 2.03140673 |
| 63 | Plagiocephaly (HP:0001357) | 2.00983447 |
| 64 | Lissencephaly (HP:0001339) | 1.99805542 |
| 65 | IgG deficiency (HP:0004315) | 1.99525682 |
| 66 | Thrombocytosis (HP:0001894) | 1.97491147 |
| 67 | Colitis (HP:0002583) | 1.97035586 |
| 68 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96466820 |
| 69 | Rectovaginal fistula (HP:0000143) | 1.95883153 |
| 70 | Rectal fistula (HP:0100590) | 1.95883153 |
| 71 | Spinal muscular atrophy (HP:0007269) | 1.94960184 |
| 72 | Recurrent sinusitis (HP:0011108) | 1.94378491 |
| 73 | Hyperthyroidism (HP:0000836) | 1.94037579 |
| 74 | Severe muscular hypotonia (HP:0006829) | 1.92355131 |
| 75 | Abnormality of the preputium (HP:0100587) | 1.91111727 |
| 76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91043914 |
| 77 | Abnormality of the thymus (HP:0000777) | 1.90798072 |
| 78 | Impaired platelet aggregation (HP:0003540) | 1.89133919 |
| 79 | Abnormal platelet function (HP:0011869) | 1.89133919 |
| 80 | Macrocytic anemia (HP:0001972) | 1.88842225 |
| 81 | Vasculitis (HP:0002633) | 1.88146913 |
| 82 | Abnormality of renal resorption (HP:0011038) | 1.87186325 |
| 83 | Increased CSF lactate (HP:0002490) | 1.86270907 |
| 84 | Nasal polyposis (HP:0100582) | 1.86243640 |
| 85 | Ankyloglossia (HP:0010296) | 1.86192582 |
| 86 | Meningitis (HP:0001287) | 1.86009051 |
| 87 | Emphysema (HP:0002097) | 1.85727778 |
| 88 | Xerostomia (HP:0000217) | 1.84283277 |
| 89 | Recurrent bacterial skin infections (HP:0005406) | 1.82116431 |
| 90 | Prominent occiput (HP:0000269) | 1.81367561 |
| 91 | Pallor (HP:0000980) | 1.80880720 |
| 92 | Leukopenia (HP:0001882) | 1.80513915 |
| 93 | Neutropenia (HP:0001875) | 1.80076706 |
| 94 | Abnormality of oral frenula (HP:0000190) | 1.80012413 |
| 95 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78118429 |
| 96 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.75924857 |
| 97 | Pigmentary retinal degeneration (HP:0001146) | 1.73718631 |
| 98 | Absent thumb (HP:0009777) | 1.73512338 |
| 99 | Papilloma (HP:0012740) | 1.73318725 |
| 100 | Verrucae (HP:0200043) | 1.73318725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 6.70032483 |
| 2 | VRK2 | 4.63354653 |
| 3 | SMG1 | 4.57854004 |
| 4 | TAF1 | 4.24965769 |
| 5 | TAOK2 | 4.06855672 |
| 6 | NME2 | 3.32471186 |
| 7 | IRAK3 | 3.06207595 |
| 8 | SIK2 | 2.79896435 |
| 9 | STK24 | 2.09932177 |
| 10 | NUAK1 | 2.04853630 |
| 11 | EPHB2 | 2.02560969 |
| 12 | MAP3K9 | 1.96006709 |
| 13 | ERBB4 | 1.84176732 |
| 14 | LIMK1 | 1.63305693 |
| 15 | MAP2K6 | 1.59138401 |
| 16 | CDK19 | 1.44253281 |
| 17 | PRKCI | 1.37867995 |
| 18 | PHKG1 | 1.36290573 |
| 19 | PHKG2 | 1.36290573 |
| 20 | CLK1 | 1.33530470 |
| 21 | MAP4K1 | 1.23703007 |
| 22 | CDC7 | 1.19277274 |
| 23 | ARAF | 1.16153442 |
| 24 | MAPKAPK5 | 1.15348366 |
| 25 | ILK | 1.13331072 |
| 26 | BUB1 | 1.11844476 |
| 27 | SIK3 | 1.08840936 |
| 28 | STK3 | 1.05869059 |
| 29 | PASK | 1.05480591 |
| 30 | TESK1 | 1.03985588 |
| 31 | WEE1 | 1.00766757 |
| 32 | STK38L | 0.99851299 |
| 33 | IKBKB | 0.96469445 |
| 34 | IRAK4 | 0.95383414 |
| 35 | PIM2 | 0.92790365 |
| 36 | VRK1 | 0.89006964 |
| 37 | MAP3K13 | 0.87970959 |
| 38 | STK4 | 0.86675012 |
| 39 | TYRO3 | 0.85555583 |
| 40 | DAPK3 | 0.85464943 |
| 41 | TBK1 | 0.84236613 |
| 42 | DAPK1 | 0.83313821 |
| 43 | MAP3K14 | 0.81399531 |
| 44 | FLT3 | 0.80689363 |
| 45 | RIPK4 | 0.76586402 |
| 46 | STK11 | 0.75344996 |
| 47 | MARK2 | 0.74182033 |
| 48 | PLK3 | 0.68910251 |
| 49 | JAK3 | 0.65894693 |
| 50 | PTK2B | 0.65501379 |
| 51 | TYK2 | 0.64638563 |
| 52 | ZAP70 | 0.61817513 |
| 53 | RIPK1 | 0.61670963 |
| 54 | PTK2 | 0.60104960 |
| 55 | IKBKE | 0.60033179 |
| 56 | CSK | 0.58712159 |
| 57 | NEK1 | 0.56976163 |
| 58 | PLK2 | 0.56455020 |
| 59 | ABL2 | 0.55738279 |
| 60 | MAPK11 | 0.55080544 |
| 61 | CDK9 | 0.54753469 |
| 62 | PRKCQ | 0.53684748 |
| 63 | PRKCH | 0.53632895 |
| 64 | EEF2K | 0.53574208 |
| 65 | SYK | 0.52423156 |
| 66 | NTRK1 | 0.51785916 |
| 67 | MAP2K3 | 0.49539202 |
| 68 | DMPK | 0.48419014 |
| 69 | DAPK2 | 0.47395149 |
| 70 | CHEK2 | 0.45807988 |
| 71 | NEK2 | 0.44968114 |
| 72 | CDK8 | 0.44744920 |
| 73 | CDK14 | 0.43917601 |
| 74 | RPS6KA2 | 0.42601982 |
| 75 | MAP3K6 | 0.42188237 |
| 76 | MARK3 | 0.40822208 |
| 77 | OXSR1 | 0.40545122 |
| 78 | MAP3K11 | 0.37766381 |
| 79 | PRKAA1 | 0.36152268 |
| 80 | EIF2AK2 | 0.35621209 |
| 81 | CSF1R | 0.34800926 |
| 82 | HIPK2 | 0.33802197 |
| 83 | CSNK1G3 | 0.31273736 |
| 84 | MAP3K12 | 0.30810865 |
| 85 | CAMKK1 | 0.29985605 |
| 86 | PTK6 | 0.29923045 |
| 87 | PAK4 | 0.28123369 |
| 88 | GRK5 | 0.27859402 |
| 89 | CDK15 | 0.26658941 |
| 90 | RPS6KA4 | 0.26129086 |
| 91 | NEK9 | 0.25435092 |
| 92 | IRAK1 | 0.24861212 |
| 93 | EPHB1 | 0.24362010 |
| 94 | CDK11A | 0.24220016 |
| 95 | LCK | 0.24147494 |
| 96 | PRKCD | 0.23033208 |
| 97 | PRKCZ | 0.22836024 |
| 98 | DYRK2 | 0.22674864 |
| 99 | TTK | 0.22530678 |
| 100 | CSNK1A1L | 0.22460827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.06466628 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.66076420 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.47904359 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.08619376 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.88153943 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.80789781 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.53278440 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.52028901 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.37093236 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.19541943 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.11332565 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04594187 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.94047826 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.91555053 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.90312718 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.81920539 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80144664 |
| 18 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.56595260 |
| 19 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.54978400 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53087386 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.45361095 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.41606405 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39381985 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.35852414 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28662078 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.26902852 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.24980362 |
| 28 | Bladder cancer_Homo sapiens_hsa05219 | 1.23272381 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.22765907 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22126225 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22090043 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.21724191 |
| 33 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17431877 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17394363 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.10114446 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09434537 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.09395997 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08459061 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08044887 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.06851805 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06443282 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.02876268 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01231555 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.00753003 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00367853 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.97469175 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 0.96860605 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91408217 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88599191 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87217996 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86594597 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86516329 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85387638 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.83957082 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.81043700 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80574541 |
| 57 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78720068 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78450239 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74947661 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.74782136 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73493721 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 0.70293605 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69722364 |
| 64 | Cell cycle_Homo sapiens_hsa04110 | 0.68246069 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67906751 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66362535 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66190846 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66180674 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63900287 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60151514 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57563220 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56542427 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55479826 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.55466352 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55425979 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53355790 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48463799 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.47848963 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47357748 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44323979 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43379769 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42727439 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.41214460 |
| 84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40506988 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39825207 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39206103 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38731800 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.38129657 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34830783 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34490590 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34333181 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.32780878 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32571675 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31298571 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31205597 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29461605 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.29363681 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29001496 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27860105 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.27047596 |

